Abstract
Neutrophil gelatinase-associated lipocalin (NGAL), a biomarker of renal injury, can bind matrix metalloproteinase-9 (MMP-9) and inhibit its degradation, thereby sustaining MMP-9 proteolytic activity. MMP-9 is produced by renal podocytes, and podocyte MMP production can be modified by high ambient glucose levels. Moreover, dysregulation of MMP-9 activity, gene expression, or urine concentrations has been demonstrated in T2DM-associated nephropathy and in non-diabetic proteinuric renal diseases. Our objective was to determine whether NGAL/MMP-9 dysregulation might contribute to or serve as a biomarker of diabetic nephropathy in type 1 DM (T1DM). Plasma MMP-9, and urine NGAL and MMP-9 concentrations were measured in 121 T1DM and 55 control subjects and examined relative to indicators of glycemia, renal function, and degree of albuminuria. T1DM was associated with a significant increase in urinary excretion of both NGAL and MMP-9, and urine NGAL:Cr (NGAL corrected to urine creatinine) and urine MMP-9:Cr concentrations were highly correlated with each other. Both were also positively correlated with measurements of glycemic control and with albuminuria. Plasma MMP-9, urine MMP-9, and urine NGAL concentrations were significantly higher in females compared to males, and urine MMP-9:Cr concentrations displayed a menstrual cycle specific pattern. Increased urinary excretion of NGAL and MMP-9 supports a role for NGAL/MMP-9 dysregulation in renal dysfunction; moreover, gender-specific differences could support a gender contribution to pathological mechanisms or susceptibility for the development of renal complications in diabetes mellitus.
Similar content being viewed by others
References
R. Visse, H. Nagase, Circ. Res. 92, 827–839 (2003)
H. Nagase, R. Visse, G. Murphy, Cardiovasc. Res. 69, 562–573 (2006)
Z. Werb, Cell 91, 439–442 (1997)
A.J. Barrett, Methods Enzymol. 80 Pt C, 737–754 (1981)
M.P. Herman, G.K. Sukhova, W. Kisiel, D. Foster, M.R. Kehry et al., J. Clin. Invest. 107, 1117–1126 (2001)
G. Derosa, I. Ferrari, A. D’Angelo, C. Tinelli, S.A. Salvadeo et al., Endothelium 15, 219–224 (2008)
B. Glowinska-Olszewska, M. Urban, Metabolism 56, 799–805 (2007)
F.M. Goncalves, A.L. Jacob-Ferreira, V.A. Gomes, A. Casella-Filho, A.C. Chagas et al., Clin. Chim. Acta 403, 173–177 (2009)
G. Derosa, A. D’Angelo, C. Tinelli, E. Devangelio, A. Consoli et al., Diabetes Metab. 33, 129–134 (2007)
G. Derosa, A.F. Cicero, F. Scalise, M.A. Avanzini, C. Tinelli et al., Endothelium 14, 45–51 (2007)
S.S. Signorelli, G. Malaponte, M. Libra, L. Di Pino, G. Celotta et al., Vasc. Med. 10, 1–6 (2005)
S. Jacqueminet, O. Ben Abdesselam, M.J. Chapman, N. Nicolay, M.J. Foglietti et al., Clin. Chim. Acta 367, 103–107 (2006)
A.K. Death, E.J. Fisher, K.C. McGrath, D.K. Yue, Atherosclerosis 168, 263–269 (2003)
G. Qing-Hua, L. Ju-Ming, P. Chang-Yu, L. Zhao-Hui, Z. Xiao-Man, M. Yi-Ming, J. Diabetes Complications 22, 408–412 (2008)
K. Tashiro, I. Koyanagi, I. Ohara, T. Ito, A. Saitoh et al., J. Clin. Lab. Anal. 18, 206–210 (2004)
A. Lauhio, T. Sorsa, R. Srinivas, M. Stenman, T. Tervahartiala et al., Ann. Med. 40, 312–320 (2008)
S. Liu, Y. Li, H. Zhao, D. Chen, Q. Huang et al., Mol. Cell. Biochem. 284, 9–17 (2006)
T. Kuroda, Y. Yoshida, J. Kamiie, P. Kovalenko, M. Nameta et al., Clin. Exp. Nephrol. 8, 206–215 (2004)
T.S. Ahuja, A. Gopalani, P. Davies, H. Ahuja, Nephron Clin. Pract. 95, c100–c104 (2003)
P. Devarajan, Scand. J. Clin. Lab. Invest. Suppl. 241, 89–94 (2008)
Y.H. Yang, X.J. He, S.R. Chen, L. Wang, E.M. Li, L.Y. Xu, Endocrine 36, 45–51 (2009)
D. Bolignano, A. Lacquaniti, G. Coppolino, V. Donato, M.R. Fazio et al., Kidney Blood Press. Res. 32, 91–98 (2009)
N. Malla, S. Sjoli, J.O. Winberg, E. Hadler-Olsen, L. Uhlin-Hansen, Connect. Tissue Res. 49, 180–184 (2008)
N. Fiotti, N. Altamura, M. Moretti, S. Wassermann, S. Zacchigna et al., Cardiovasc. Drugs Ther. 23, 153–159 (2009)
H. Kramer, M.E. Molitch, Diabetes Care 28, 1813–1816 (2005)
American Diabetes Association, Diabetes Care 26, 94S–98S (2003)
K.M. Thrailkill, R.C. Bunn, C.S. Moreau, G.E. Cockrell, P.M. Simpson et al., Diabetes Care 30, 2321–2326 (2007)
K.M. Thrailkill, C.S. Moreau, G. Cockrell, P. Simpson, R. Goel et al., Clin. Chem. Lab. Med. 43, 1392–1399 (2005)
American Diabetes Association, Diabetes Care 32(Suppl 1), S13–S61 (2009)
C.A. Paris, G. Imperatore, G. Klingensmith, D. Petitti, B. Rodriguez et al., J. Pediatr. 155, 183–189.e1 (2009)
K.M. Thrailkill, T. Nimmo, R.C. Bunn, G.E. Cockrell, C.S. Moreau et al., Diabetes Care 32, 1266–1268 (2009)
H. Birn, Am. J. Physiol. Renal Physiol. 291, F22–F36 (2006)
V. Hvidberg, C. Jacobsen, R.K. Strong, J.B. Cowland, S.K. Moestrup, N. Borregaard, FEBS Lett. 579, 773–777 (2005)
P.E. Van den Steen, I. Van Aelst, V. Hvidberg, H. Piccard, P. Fiten et al., J. Biol. Chem. 281, 18626–18637 (2006)
L. Yan, N. Borregaard, L. Kjeldsen, M.A. Moses, J. Biol. Chem. 276, 37258–37265 (2001)
N. Engl. J. Med. 329, 977–986 (1993)
H.L. Huang, S.T. Chu, Y.H. Chen, J. Endocrinol. 162, 11–19 (1999)
P. Seth, D. Porter, J. Lahti-Domenici, Y. Geng, A. Richardson, K. Polyak, Cancer Res. 62, 4540–4544 (2002)
R.W. Mankhey, C.C. Wells, F. Bhatti, C. Maric, Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R769–R777 (2007)
D.Z. Cherney, E.B. Sochett, J.A. Miller, Kidney Int. 68, 1722–1728 (2005)
Acknowledgements
The authors appreciate the critical review of this manuscript provided by Dr. Lindsey Clark. This work was supported by grants from the National Institutes of Health to KMT (R01-DK62999), to the UAMS General Clinical Research Center (M01 RR14288) and to the Arkansas Children’s Hospital Research Institute (C06RR16517).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thrailkill, K.M., Moreau, C.S., Cockrell, G.E. et al. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocr 37, 336–343 (2010). https://doi.org/10.1007/s12020-010-9308-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9308-6